Dominik Leisi

Dominik joined Atlantic Bridge as a Senior Investment Associate on the University Bridge Fund in 2022. Prior to joining Atlantic Bridge, Dominik was an Investment Manager in the Life Science Team of the University College London (UCL) Technology Fund which is managed by Albion Capital. Before joining the UCL Technology Fund, Dominik was responsible for the commercialisation of technologies that originated at the UCL Cancer Institute and the UCL GOSH Institute of Child Health. He has also held different R&D roles within the medical device and speciality pharmaceutical industries. Dominik holds a BSc in Life Sciences Technologies from the University of Northern Switzerland and a MSc in Innovation and Management from Imperial College Business School.